ENDONOVO THERAPEUTICS, INC. — Form D/A

ENDONOVO THERAPEUTICS, INC. of WOODLAND HILLS, CA, a company, filed a Form D amendment with the SEC on 2014-08-11. The offering totals $500K, of which $483K was reported sold. Industry: Biotechnology.

Offering

Filed: 2014-08-11
Form: D/A
Accession: 0001528172-14-000002
Industry: Biotechnology
Exemptions: 06c
Total offering: $500K
Amount sold: $483K
Remaining: $17K
Minimum investment: $5K
Investors: 19
Date of first sale: 2013-10-31
Security types: equity, debt
Revenue range: $1 - $1,000,000
SEC file number: 021-206405

Issuer

Name: ENDONOVO THERAPEUTICS, INC.
CIK: 0001528172
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2011
Address: 6320 CANOGA AVENUE, WOODLAND HILLS, CA, 91367
Phone: (800) 489-4774

Officers, directors & promoters (5)

Name	Role	Location
Michael Mann	Executive Officer	Dallas, TX
Collier Collier	Director	Woodland Hills, CA
Collier Collier	Executive Officer	Woodland Hills, CA
Alan Collier	Director	Woodland Hills, CA
Alan Collier	Executive Officer	Woodland Hills, CA

Other filings by this issuer (8)

Filed	Form	Offering	Sold
2019-11-22	D	$2.0M	$225K
2017-12-29	D	$8.0M	$700K
2016-02-19	D	$5.0M	$211K
2014-12-09	D	$500K	$105K
2014-12-03	D	$25K	$13K
2014-12-03	D/A	$500K	$50K
2014-09-05	D	$500K	$25K
2013-11-15	D	$500K	$10K

More